Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Etalon Group sold 87% more real estate in 2023

1/16/24 ETLN

Fix Price's Board of Directors declared an interim dividend

1/16/24 FIXP

TCS Group shareholders approved the redomiciliation

1/16/24 T

MFK CarMoney will be headed by Elena Yashina

1/15/24 CARM

MTS has increased its share in scooter rental service Yurent to 80.6%

1/15/24 MTSS

On VK Video released 1.5 thousand exclusive projects over the year

1/15/24 VKCO

Histograft investigates gene-activated material for spine treatment

1/15/24 ABIO

Sollers attracted a soft loan of ₽3.4 billion

1/15/24 SVAV

Hard discounter chain B1 plans to accelerate the pace of expansion

1/15/24 MGNT

Mosgorlombard's loan portfolio grew by 71% in 2023

1/15/24 MGKL